Skip to content

VA breath check quit program

Veteran Health Incentive Pilot: Financial Incentives for Tobacco Cessation (VHIP-FITC)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN47063982
Enrollment
1399
Registered
2026-07-30
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation Mental and Behavioural Disorders

Interventions

Using a pragmatic, patient-level, randomized design, Veterans who smoke cigarettes will be randomized in a 1:1 ratio to one of two intervention groups: Enhanced Usual Care or Enhanced Usual Care + Fin

Sponsors

Center for Innovation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age =18 2. Enrolled in VA health care 3. Assigned to a primary care provider in a participating VISN (currently 4, 12, 17, 20) 4. Has a valid mailing and/or email address on file 5. Currently smokes cigarettes: 5.1. Reported as a current tobacco user per clinical data in the EHR 5.2. Self-reported having smoked =5 cigarettes per day at the time of recruitment call 5.3. CO pre-enrollment verification of smoking status (=8 PPM) 6. Willing to set a quit date within 2–60 days of the first pharmacist visit 7. Device/internet capable (assessed via digital divide consult if needed) 8. Able to receive payment via direct deposit and enrolled in EFT prior to randomization

Exclusion criteria

Exclusion criteria: 1. Enrolled in hospice care or diagnosed with a condition where there is less than 12 months of expected survival 2. Diagnosis of cognitive impairment 3. No phone contact on file 4. Unwilling or unable to participate in telemedicine visits

Design outcomes

Secondary

MeasureTime frame
7-day, CO verified abstinence at 12-month follow-up measured using PPM at 12-month follow up;6-month prolonged abstinence at 6 and 12 month follow-up measured using self reporting at 6 and 12 month follow ups;Quality of life measured using the EUROQOL EQ-5D instrument at 12 month follow up;Cost-effectiveness measured using Incremental Cost-Effectiveness Ratio (ICER) at 6 month follow up

Primary

MeasureTime frame
7-day point abstinence measured using CO verified at 6-month follow up

Countries

United States of America

Contacts

Public ContactAnne Melzer
Anne.Melzer2@va.gov+1 612-725-4400

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026